Elecsys® AFP
... . Dunstan FDJ, Gray JC, Nix ABJ, et al. Detection rates and false positive rates for Down’s Syndrome ... Down’s Syndrome Rates. Hum Genet Vol 1981;59:232-234. Cuckle HS. Improved parameters for risk estimation ... , Nix ABJ, et al. Detection rates and false positive rates for Down’s Syndrome screening: How precisely ... Rates. Hum Genet Vol 1981;59:232-234. Cuckle HS. Improved parameters for risk estimation in Down’s ...
Global Access Program
... programa integral de acceso al diagnóstico. Estimated TB incidence rates in 20201 Ninguna acción aislada ... rates in 2020 1 Ninguna acción aislada resolverá por sí sola este problema sanitario mundial. Los ...
NAVIFY® Clinical Decision Support apps
... . Bornmann L, Rüdiger M. “Growth rates of modern science: A bibliometric analysis based on the number of ... . Bornmann L, Rüdiger M. “Growth rates of modern science: A bibliometric analysis based on the number of ...
Prueba VENTANA ALK (D5F3) CDx (aprobada por la FDA de los EE. UU.)
... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ...
Anticuerpo primario monoclonal de conejo contra ALK (D5F3) VENTANA ...
... . 6. Lung Cancer Survival Rates and Prognosis. National Cancer Institute at the National Institutes of ... . Fecha de acceso: 1 de agosto de 2014. 6. Lung Cancer Survival Rates and Prognosis. National Cancer ...
